US › Healthcare

Trinity Biotech plc (TRIB)

US · Healthcare · Medical Devices

$7.26+3.34%

Last close · 2026-09-17

Latest quarter · ended 2026-03-31

Revenue

$11.1M

Revenue YoY

-27.0%

Net profit

$-17.5M

EPS

$-28.12

Net margin

-157.8%

Key statistics

Market cap

$5.7M

Forward P/E

4.5

P/B

5.75

Book value

$-115.42

EPS (TTM)

$-60.00

52-week high

$52.50

52-week low

$6.85

50-day MA

$10.42

200-day MA

$18.74

Beta

0.97

Analyst view

Analysts rate Trinity Biotech plc a strong buy (1 buy, 0 hold, 0 sell out of 1) with an average price target of $3.00.

Shareholding

Insiders

13.77%

Institutions

4.07%

Largest institutional holders

Fund	Stake
Hunter Associates Inc.	2.71%
Williams & Novak LLC	0.58%
Virtu Financial LLC	0.11%
Moss Adams Wealth Advisors LLC	0.11%
Integrys Wealth Advisors LLC	0.10%
CAMBRIDGE Invest RESEARCH ADVISORS, INC.	0.09%
Becker Capital	0.07%
Renaissance Technologies Corp	0.07%

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Trinity Biotech plc — free to start.

Google Play App Store

Other Healthcare companies

Eli Lilly and Company Johnson & Johnson AbbVie Inc Merck & Company Inc UnitedHealth Group Incorporated Novartis AG ADR AstraZeneca PLC Thermo Fisher Scientific Inc Amgen Inc Novo Nordisk A/S Gilead Sciences Inc Abbott Laboratories

Data updated 2026-09-18.